Tonix plans to initiate potential pivotal Phase 2 HORIZON study of TNX-102 SL in adults with major depressive disorder in mid-2026More than 21 ...

Co-occurring ADHD and substance use create unique challenges. The latest research shows what effective treatment really requires.

The FDA has approved Caplyta as adjunctive therapy with antidepressants to treat major depressive disorder in adults, according to the manufacturer. In a press release, Johnson & Johnson said the ...

aDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada bNational Collaborating Centre for Methods and Tools, McMaster University, Hamilton, ON, Canada ...

Researchers from Harvard’s Department of Human Evolutionary Biology found that educated children perform better on psychological tests measuring executive function abilities, challenging the accuracy ...

If your anger or defiant behavior is really getting in the way of relationships, career goals, and other aspects of your life, but you’re unable to curb your emotional impulses, you may have a problem ...

A wearable sensor could make tracking medication levels much easier for people living with bipolar disorder, eliminating the need for blood draws and lab analyses. The first-of-its-kind device could ...

Section 1. Purpose and Policy. Endemic vagrancy, disorderly behavior, sudden confrontations, and violent attacks have made our cities unsafe. The number of individuals living on the streets in the ...

Attention-deficit/hyperactivity disorder (ADHD) is a childhood-onset neurobiological disorder that often persists into adulthood. Adult ADHD is an important public ...

This valuable study marks a significant advancement in brain aging research by centering on Asian populations (Chinese, Malay, and Indian Singaporeans), a group frequently underrepresented in such ...